Drug recall · April 9, 2014
Suprax, Cefixime for Oral Suspension USP 500 mg/5 ml recall
Why: Failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Suprax, Cefixime for Oral Suspension USP 500 mg/5 ml, 10mL (when reconstituted), Rx only, Manufactured for Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, MD 21202, Manufactured by Lupin Limited Mumbai 400 058 India, NDC 27437-207-02.
- Lots / codes
Lot #s: F300737 Exp. February 2015, F300743 Exp. February 2015
- Quantity
- 4,038 bottles
- Company
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Distribution
- Nationwide
- Initiated
- January 27, 2014 · Voluntary: Firm initiated
- Classified
- April 2, 2014
- Reported
- April 9, 2014
- Ended
- May 12, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cefixime
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.